China Universal Asset Management Company’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $2.44M | Sell |
|
|||||
|
2025
Q2 | $2.5M | Sell |
|
|||||
|
2025
Q1 | $2.21M | Sell |
|
|||||
|
2024
Q4 | $2.93M | Buy |
|
|||||
|
2024
Q3 | $2.24M | Buy |
|
|||||
|
2024
Q2 | $1.63M | Sell |
|
|||||
|
2024
Q1 | $2.64M | Buy |
|
|||||
|
2023
Q4 | $1.5M | Buy |
|
|||||
|
2023
Q3 | $282K | Buy |
|
|||||
|
2023
Q2 | $121K | Sell |
|
|||||
|
2023
Q1 | $132K | Buy |
|
|||||
|
2022
Q4 | $117K | Buy |
|
|||||
|
2022
Q3 | $95K | Buy |
|